Cadrenal Therapeutics News

Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 15 06:04

Cadrenal Therapeutics | 8-K: Current report

Nov 7 22:13

Cadrenal Therapeutics | 8-K: Current report

Nov 5 05:44

Cadrenal Therapeutics | 8-K: Current report

Oct 24 21:13

Cadrenal Therapeutics | 8-K: Current report

Sep 26 04:11

Cadrenal Therapeutics | 8-K: Current report

Sep 6 05:04

Cadrenal Therapeutics | 8-K: Current report

Aug 20 18:08

Cadrenal Therapeutics | 8-K: Current report

Aug 16 18:09

Cadrenal Therapeutics | 8-K: Current report

Aug 9 04:57

Cadrenal Therapeutics | 8-K: Current report

Aug 6 21:13

Cadrenal Therapeutics | 8-K: Current report

Aug 1 04:08

Cadrenal Therapeutics | DEFA14A: Others

Jun 13 04:17

Cadrenal Therapeutics | DEF 14A: Definitive information statements

Jun 12 05:28

Cadrenal Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 30 05:33

Cadrenal Therapeutics | 8-K: Current report

May 10 01:03

Cadrenal Therapeutics | 8-K: Current report

Apr 9 21:30

Cadrenal Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 3 00:58

Cadrenal Therapeutics | 8-K: Current report

Mar 13 00:54

Cadrenal Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 20:42

Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 12 20:07